The primary goals of AI personalization were to improve onboarding, boost medication initiation and adherence, and enhance physician follow-up. AllazoHealth’s artificial intelligence (AI)-powered ...

New research indicates that obinutuzumab is a potentially effective and cost-effective treatment for patients with rituximab-resistant AAV. Obinutuzumab therapy demonstrated immunological superiority ...

Immunohistochemistry analyses detected a correlation between increased CDK1 expression and higher levels of LDH, a key indicator of greater disease severity in DLBCL. Higher levels of CDK1 expression ...

Between 1970 and 1995, the incidence of new NHL cases increased. Between 2007 and 2016, new cases declined by approximately 0.9% per year, and mortality from NHL decreased by 2.2% per year. 3 ...

The patient’s RA was managed with leflunomide and etanercept for the past 5 years. Researchers from the US presented the case of a patient with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) ...

The expression of AQP4 In the respiratory epithelium suggests that lung involvement might be an unrecognized feature of NMOSD. Patients with neuromyelitis optica spectrum disorder (NMOSD) should be ...

Higher macrophage density in the tubulointerstitium was associated with progression to end-stage kidney disease. A new study has evaluated the density and prognostic significance of CD68+ macrophages ...

Obeticholic acid, seladelpar, and elafibranor all significantly increased the biochemical response rate. Elafibranor seems to be slightly more effective than seladelpar as a second-line therapy in ...

Dried blood spot screening is potentially a powerful tool for screening HAE in at-risk populations. An outreach program using dried blood spot (DBS) tests is a promising strategy to overcome family ...

Twelve months after ASCT, chronic hemolysis is ongoing, but the patient is now transfusion-free, and the lymphoma is in continuous remission. Performing autologous stem cell transplantation (ASCT) in ...

The median levels of serum neurofilament light chain (sNfL) were greater in patients with CIDP who were treatment-naive compared to those who were on maintenance therapy. The levels of serum ...

Hemolysis ceased completely in 2 patients after receiving 20 mg of rituximab. Low-dose rituximab may offer transient efficacy in patients with autoimmune hemolytic anemia (AIHA), including those with ...